The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

L. Joost van Pelt; Michael V. Lukens; Sophie Testa; Bernard Chatelain; Jonathan Douxfils; Francois Mullier

doi:10.1016/j.thromres.2018.04.024

The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

L. Joost van Pelt^*, Michael V. Lukens, Sophie Testa, Bernard Chatelain, Jonathan Douxfils, Francois Mullier

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	63-66
Number of pages	4
Journal	Thrombosis Research
Volume	168
DOIs	https://doi.org/10.1016/j.thromres.2018.04.024
Publication status	Published - Aug-2018

Keywords

DIRECT ORAL ANTICOAGULANTS

Access to Document

10.1016/j.thromres.2018.04.024

Handle.net

Persistent link

Embargoed Document

The DaXa-inhibition assay
Final publisher's version, 358 KB

Cite this

@article{dfaff8e70c944ed995325e7a7dd51bfa,

title = "The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs",

keywords = "DIRECT ORAL ANTICOAGULANTS",

author = "{van Pelt}, {L. Joost} and Lukens, {Michael V.} and Sophie Testa and Bernard Chatelain and Jonathan Douxfils and Francois Mullier",

year = "2018",

month = aug,

doi = "10.1016/j.thromres.2018.04.024",

language = "English",

volume = "168",

pages = "63--66",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

}

TY - JOUR

T1 - The DaXa-inhibition assay

T2 - A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

AU - van Pelt, L. Joost

AU - Lukens, Michael V.

AU - Testa, Sophie

AU - Chatelain, Bernard

AU - Douxfils, Jonathan

AU - Mullier, Francois

PY - 2018/8

Y1 - 2018/8

KW - DIRECT ORAL ANTICOAGULANTS

U2 - 10.1016/j.thromres.2018.04.024

DO - 10.1016/j.thromres.2018.04.024

M3 - Letter

SN - 0049-3848

VL - 168

SP - 63

EP - 66

JO - Thrombosis Research

JF - Thrombosis Research

ER -